NuPulse is not simply a capital provider. It is a strategic translation layer between inventors, physicians, investors, and acquirers.
Our focus is deliberately narrow. Cardiovascular and electrophysiology is the sector our founders have practised in and advised for more than fifteen years, and that depth determines which clinicians we can call on, which evidence will withstand scrutiny, and which acquirers are genuinely in the market.
We increase the probability of attractive outcomes by identifying strategic value earlier, strengthening clinical validation, and preparing companies for the milestones investors and strategic partners evaluate.